Target Name: LOC105379144
NCBI ID: G105379144
Review Report on LOC105379144 Target / Biomarker Content of Review Report on LOC105379144 Target / Biomarker
LOC105379144
Other Name(s): LOC105379144 variant X1 | Uncharacterized LOC105379144, transcript variant X1 | uncharacterized LOC105379144

LOC105379144: A unique protein with potential drug and biomarker applications

LOC105379144 (LOC105379144 variant X1) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased levels of thermal stress in the body.

LOC105379144 variant X1 is unique because it has a unique structure compared to other HSPs. Unlike other HSPs, LOC105379144 has a distinct N-terminus and a unique C-terminus. " and it is the region that is involved in the formation of the protein's alpha-helices, which are the primary structure of the protein. The C-terminus is known as the \"beta-sheet region,\" and it is the region that is involved in the formation of the protein's beta-sheet structure.

LOC105379144 variant X1 is also unique because it is expressed in various tissues of the body, including the brain. The brain is a vital organ that is responsible for the function of the body, and it is important that the brain be healthy and functioning. Therefore , studying the expression of LOC105379144 variant X1 in the brain is important for understanding how the body's cells respond to different conditions and for the development of potential therapeutic strategies for various neurological and psychiatric disorders.

In addition to its unique structure and its expression in the brain, LOC105379144 variant X1 is also of interest as a potential drug target. The HSP70 family of proteins, which includes LOC105379144 variant X1, have been shown to play a role in a variety of cellular processes, including the regulation of cell survival, the response to stress, and the regulation of inflammation. Therefore, targeting HSP70 proteins, including LOC105379144 variant X1, could be a promising strategy for the development of new drugs for various diseases.

LOC105379144 variant X1 is also of interest as a potential biomarker for certain diseases. The expression of LOC105379144 variant X1 in various tissues of the body, including the brain, could be used as a biomarker for certain diseases, such as neurodegenerative disorders, Alzheimer's disease, and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to be caused by the build-up of beta-amyloid plaques in the brain. Therefore, studying the expression of LOC105379144 variant X1 in the brain could be a promising strategy for the diagnosis and treatment of these conditions.

In conclusion, LOC105379144 (LOC105379144 variant X1) is a protein that is expressed in various tissues of the human body, including the brain. Its unique structure, including the distinct N-terminus and beta-sheet region, and its expression in the brain make it an interesting candidate for study as a potential drug target or biomarker. Further research is needed to determine the role of LOC105379144 variant X1 in the regulation of cellular processes and to study its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105379144

The "LOC105379144 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379144 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782